Stock Research for XOMA


Featured Broker: Ally Invest

Get the due diligence for another stock.


XOMA Stock Chart & Research Data

The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


XOMA Due diligence Resources & Stock Charts

The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View XOMA Detailed Price Forecast - CNN Money CNN View XOMA Detailed Summary - Google Finance
Yahoo View XOMA Detailed Summary - Yahoo! Finance Zacks View XOMA Stock Research & Analysis -

Stock Analysis

TradeIdeas View XOMA Trends & Analysis - Trade-Ideas Barrons View XOMA Major Holders - Barrons
NASDAQ View XOMA Call Transcripts - NASDAQ Seeking View XOMA Breaking News & Analysis - Seeking Alpha
Spotlight View XOMA Annual Report - OTC Report View XOMA OTC Short Report -
TradeKing View XOMA Fundamentals - TradeKing Charts View XOMA SEC Filings - Bar Chart
WSJ View Historical Prices for XOMA - The WSJ Morningstar View Performance/Total Return for XOMA - Morningstar
MarketWatch View the Analyst Estimates for XOMA - MarketWatch CNBC View the Earnings History for XOMA - CNBC
StockMarketWatch View the XOMA Earnings - StockMarketWatch MacroAxis View XOMA Buy or Sell Recommendations - MacroAxis
Bullish View the XOMA Bullish Patterns - American Bulls Short Pains View XOMA Short Pain Metrics -

Social Media Mentions

StockTwits View XOMA Stock Mentions - StockTwits PennyStocks View XOMA Stock Mentions - PennyStockTweets
Twitter View XOMA Stock Mentions - Twitter Invest Hub View XOMA Investment Forum News - Investor Hub
Yahoo View XOMA Stock Mentions - Yahoo! Message Board Seeking Alpha View XOMA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for XOMA - Insider Cow View Insider Transactions for XOMA - Insider Cow
CNBC View XOMA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for XOMA - OTC Markets
Yahoo View Insider Transactions for XOMA - Yahoo! Finance NASDAQ View Institutional Holdings for XOMA - NASDAQ

Stock Charts

FinViz View XOMA Stock Insight & Charts - StockCharts View XOMA Investment Charts -
BarChart View XOMA Stock Overview & Charts - BarChart Trading View View XOMA User Generated Charts - Trading View

Latest Financial News for XOMA

XOMA to Present at the H.C. Wainwright Global Life Sciences Conference
Posted on Tuesday April 03, 2018

EMERYVILLE, Calif., April 03, 2018-- XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present ...

Investor Expectations to Drive Momentum within Key Energy Services, XOMA, Goldman Sachs BDC, Echo Global Logistics, Ellington Residential Mortgage REIT, and Phibro Animal Health — Discovering Underlying Factors of Influence
Posted on Tuesday March 20, 2018

NEW YORK, March 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

Xoma reports 4Q loss
Posted on Wednesday March 07, 2018

The Berkeley, California-based company said it had a loss of 16 cents per share. The drug developer posted revenue of $5.4 million in the period. For the year, the company reported net income of $14.6 ...

XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Posted on Wednesday March 07, 2018

Transformed business model to a royalty aggregator with extensive asset portfolio and capital; Added nine new partner-funded programs in 2017 with potential for milestone and royalty payments; Current ...

Enter a stock symbol to view the stock details.